vs
Ensysce Biosciences, Inc.（ENSC）与Professional Diversity Network, Inc.（IPDN）财务数据对比。点击上方公司名可切换其他公司
Ensysce Biosciences, Inc.的季度营收约是Professional Diversity Network, Inc.的1.1倍（$1.9M vs $1.7M），Ensysce Biosciences, Inc.净利率更高（-147.0% vs -173.5%，领先26.4%），Ensysce Biosciences, Inc.同比增速更快（44.4% vs 3.1%），过去两年Ensysce Biosciences, Inc.的营收复合增速更高（107.9% vs -1.7%）
Ensysce Biosciences是一家临床阶段生物技术公司，专注于开发疼痛管理和肿瘤适应症领域的创新前药疗法，其专有平台可降低阿片类药物滥用风险并提升治疗有效性，面向全球医疗医药市场，重点解决未被满足的临床需求。
Professional Diversity Network, Inc.是一家总部位于美国的多元、公平与包容（DEI）解决方案服务商，面向各行业企业客户提供弱势群体定向招聘、DEI定制化培训、多元表现数据分析等服务，覆盖科技、医疗、金融等多个核心商业领域。
ENSC vs IPDN — 直观对比
营收规模更大
ENSC
是对方的1.1倍
$1.7M
营收增速更快
ENSC
高出41.3%
3.1%
净利率更高
ENSC
高出26.4%
-173.5%
两年增速更快
ENSC
近两年复合增速
-1.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.9M | $1.7M |
| 净利润 | $-2.8M | $-2.9M |
| 毛利率 | — | 33.7% |
| 营业利润率 | -147.8% | -173.2% |
| 净利率 | -147.0% | -173.5% |
| 营收同比 | 44.4% | 3.1% |
| 净利润同比 | 22.3% | -280.0% |
| 每股收益（稀释后） | $-0.51 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENSCIPDN
| Q4 25 | $1.9M | $1.7M | ||
| Q3 25 | $493.1K | $1.7M | ||
| Q2 25 | $1.4M | $1.6M | ||
| Q1 25 | $1.3M | $1.5M | ||
| Q4 24 | $1.3M | $1.6M | ||
| Q3 24 | $3.4M | $1.7M | ||
| Q2 24 | — | $1.7M | ||
| Q1 24 | — | $1.7M |
净利润ENSCIPDN
| Q4 25 | $-2.8M | $-2.9M | ||
| Q3 25 | $-3.7M | $-2.4M | ||
| Q2 25 | $-1.7M | $-476.0K | ||
| Q1 25 | $-1.9M | $-722.1K | ||
| Q4 24 | $-3.6M | $-761.9K | ||
| Q3 24 | $661.8K | $-405.0K | ||
| Q2 24 | — | $-553.1K | ||
| Q1 24 | — | $-791.8K |
毛利率ENSCIPDN
| Q4 25 | — | 33.7% | ||
| Q3 25 | — | 44.0% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.9% | ||
| Q2 24 | — | 62.9% | ||
| Q1 24 | — | 62.2% |
营业利润率ENSCIPDN
| Q4 25 | -147.8% | -173.2% | ||
| Q3 25 | -758.7% | -136.3% | ||
| Q2 25 | -127.6% | -30.2% | ||
| Q1 25 | -149.1% | -46.9% | ||
| Q4 24 | -274.3% | -36.8% | ||
| Q3 24 | 18.9% | -25.0% | ||
| Q2 24 | — | -34.4% | ||
| Q1 24 | — | -46.5% |
净利率ENSCIPDN
| Q4 25 | -147.0% | -173.5% | ||
| Q3 25 | -756.3% | -136.2% | ||
| Q2 25 | -126.4% | -29.0% | ||
| Q1 25 | -147.4% | -48.0% | ||
| Q4 24 | -273.4% | -47.1% | ||
| Q3 24 | 19.4% | -23.9% | ||
| Q2 24 | — | -32.7% | ||
| Q1 24 | — | -45.9% |
每股收益（稀释后）ENSCIPDN
| Q4 25 | $-0.51 | — | ||
| Q3 25 | $-1.29 | — | ||
| Q2 25 | $-0.79 | — | ||
| Q1 25 | $-1.39 | — | ||
| Q4 24 | $-0.89 | — | ||
| Q3 24 | $1.00 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $217.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.2M | $11.7M |
| 总资产 | $7.5M | $17.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ENSCIPDN
| Q4 25 | $4.3M | $217.0K | ||
| Q3 25 | $1.7M | $265.3K | ||
| Q2 25 | $2.2M | $125.1K | ||
| Q1 25 | $3.1M | $496.4K | ||
| Q4 24 | $3.5M | $1.7M | ||
| Q3 24 | $4.2M | $133.7K | ||
| Q2 24 | — | $619.3K | ||
| Q1 24 | — | $97.1K |
股东权益ENSCIPDN
| Q4 25 | $3.2M | $11.7M | ||
| Q3 25 | $1.2M | $8.9M | ||
| Q2 25 | $3.4M | $4.5M | ||
| Q1 25 | $3.0M | $4.9M | ||
| Q4 24 | $3.7M | $5.3M | ||
| Q3 24 | $6.9M | $2.1M | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $2.3M |
总资产ENSCIPDN
| Q4 25 | $7.5M | $17.9M | ||
| Q3 25 | $3.2M | $12.1M | ||
| Q2 25 | $5.6M | $7.3M | ||
| Q1 25 | $4.6M | $7.7M | ||
| Q4 24 | $5.6M | $8.0M | ||
| Q3 24 | $9.4M | $5.3M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | — | $5.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $1.4M |
| 自由现金流经营现金流 - 资本支出 | — | $1.4M |
| 自由现金流率自由现金流/营收 | — | 84.4% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ENSCIPDN
| Q4 25 | $-1.5M | $1.4M | ||
| Q3 25 | $-1.9M | $-2.7M | ||
| Q2 25 | $-2.7M | $-495.5K | ||
| Q1 25 | $-1.7M | $-284.1K | ||
| Q4 24 | $-764.1K | $-1.2M | ||
| Q3 24 | $-1.0M | $-556.9K | ||
| Q2 24 | — | $-224.4K | ||
| Q1 24 | — | $-543.1K |
自由现金流ENSCIPDN
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $-2.7M | ||
| Q2 25 | — | $-499.5K | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-558.9K | ||
| Q2 24 | — | $-225.9K | ||
| Q1 24 | — | $-543.6K |
自由现金流率ENSCIPDN
| Q4 25 | — | 84.4% | ||
| Q3 25 | — | -156.8% | ||
| Q2 25 | — | -30.4% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -74.0% | ||
| Q3 24 | — | -33.0% | ||
| Q2 24 | — | -13.4% | ||
| Q1 24 | — | -31.5% |
资本支出强度ENSCIPDN
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% |
现金转化率ENSCIPDN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
